JOURNAL OF CLINICAL ONCOLOGY Journal
Overview
publication venue for
- First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors. 38:1824-+. 2020
- Similar response rates and survival with PARPi treatments for patients harboring somatic versus germline BRCA mutations: A meta-analysis and systematic review.. 38:e16802-e16802. 2020
- Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery. 32:774-782. 2014
- Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators.. 12:1796-1805. 1994
- Chronic leukemias and COVID-19: An analysis of mortality and morbidity outcomes in the United States 2023
- Colorectal cancer mortality in young adults in the United States 2023
- Demographic disparities in lung cancer mortality and trends in the United States between 1999 and 2020: A population-based CDC database analysis 2023
- Effect of COVID-19 on mortality in patients admitted for DVT/PE with pre-existing cancer diagnosis at the beginning of the COVID-19 pandemic: A national inpatient sample study 2023
- First-in-human dose-escalation study of NBF-006, a novel investigational siRNA targeting GSTP, in patients with non-small cell lung, pancreatic, or colorectal cancer. 2023
- Risk factors for in-hospital mortality in cancer patients hospitalized for COVID-19 2023
- Trends in hepatocellular carcinoma rates by age, region, race, and ethnicity: A SEER database population study 2000-2019. 2023
- yyEfficacy of immune-checkpoint inhibitor (ICI) combination as a first-line (1L) therapy in metastatic renal cell carcinoma (mRCC) with sarcomatoid histology: A systematic review and meta-analysis. 2023
- Quality of educational YouTube videos related to pancreatic cancer: Analysis of patient-focused and NCI-designated cancer center videos. 2023
- E-cigarette use and the risk of bladder and lung cancer. 2022
- Financial toxicity and its effect on screening for prostate and colon cancer. 2022
- A retrospective study of characteristics and survival in patients with breast cancer brain metastases classified by subtype using NCI SEER registry. 2021
- Comparison of survival outcomes with the use of combination chemoimmunotherapy versus immunotherapy alone in NSCLC with high PD-L1 expression. 2021
- Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A real-world perspective. 2021
- Multivalent state transitions regulate the intratumoral composition of small cell lung carcinoma. 2021
- Racial and ethnic representation trends in United States oncology training programs. 2021
- Representation trends in radiation oncology training programs in the United States. 2021
- A retrospective study of characteristics and survival in patients with breast cancer brain metastases classified by subtype using NCI SEER registry. 2021
- Racial and ethnic representation trends in United States oncology training programs. 2021
- Representation trends in radiation oncology training programs in the United States. 2021
- Liquid biopsy: Safety and efficacy in a tool for molecular profiling of advanced non-small cell lung cancer (NSCLC). 2020
- Safety and efficacy of pemigatinib plus pembrolizumab combination therapy in patients (pts) with advanced malignancies: Results from FIGHT-101, an open-label phase I/II study. 2020
- Similar response rates and survival with PARPi treatments for patients harboring somatic versus germline BRCA mutations: A meta-analysis and systematic review. 2020
- Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage 2020
- Variance in symptom assessment between patient and caregiver: A prospective study of patients staged as metastatic prostate cancer-An interim analysis 2020
- Progression free survival (PFS) benefits of immuno-oncology agents (IOs) and implications for market cost-sharing inefficiencies. 2019
- Retrospective analysis of outcomes of cisplatin (CDDP) versus non cisplatin based treatment regimens for concurrent chemoradiotherapy (CCRT) in locally advanced squamous cell head and neck cancer (LA-SCCHN). 2019
- T-cell lymphoma secondary to checkpoint inhibitor (CPI) used for other malignancies. 2019
- A phase II, multicenter, single-arm trial of CV301 plus atezolizumab (Atezo) in locally advanced (unresectable) or metastatic urothelial cancer (UC). 2019
- Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability high (MSI-H) tumors. 2019
- Retrospective analysis of outcomes of cisplatin (CDDP) versus non cisplatin based treatment regimens for concurrent chemoradiotherapy (CCRT) in locally advanced squamous cell head and neck cancer (LA-SCCHN). 2019
- Phase 1b results of avelumab in patients (pts) with previously treated metastatic melanoma enrolled in the JAVELIN Solid Tumor trial, including updated subgroup analyses. 2018
- Phase 1b study of TAK-659+nivolumab (nivo) in patients (pts) with advanced solid tumors. 2018
- Phase 1b study of avelumab in advanced previously treated mesothelioma: long-term follow-up from JAVELIN Solid Tumor. 2018
- Precision oncology: Results of a phase I study of M2698, a p70S6K/AKT targeted agent in patients with advanced cancer and tumor PI3K/AKT/mTOR (PAM) pathway abnormalities. 2018
- Regional socio-demographic determinants of breast cancer incidence in the United States. 2018
- Regional socio-demographic determinants of melanoma incidence in the United States. 2018
- Safety and clinical activity of durvalumab monotherapy in patients with gastroesophageal cancers. 2018
- Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). 2018
- The epidemiology of carcinoid tumors of small and large intestine in USA: A national inpatient sample analysis (2009-2014) 2018
- Understanding melanoma patients’ needs in the new era of treatment: A mixed-methods approach. 2018
- Conditional survival estimates for patients with plasma cell leukemia: An analysis of the SEER database. 2017
- Prophylactic anticoagulation to benefit younger patients under 65 years of age with metastatic lung cancer: An analysis of the 2013 Healthcare Cost and Utilization Project (HCUP) data. 2017
- Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM). 2017
- Temporal trend in the use of surgery in the management of stage IIIa non-small cell lung cancer (NSCLC) between 2000-2013: A SEER analysis. 2017
- Racial disparities among patients with metastatic lung disease. 2016
- The impact of published guidelines on chemotherapy dosing in overweight and obese patients in the adjuvant setting: A single institution experience. 2016
- Type of surgery for early breast cancer and predictive factors an institutional review: A regression model 2013
- A pilot study of the immunohistochemical pattern of neuropilin-2 (NRP2) labeling and correlation with tumor stage in colon cancer 2012
- Conditional survival of patients with esophageal cancer: A SEER database analysis. 2011
- Breast cancer survivors’ motivation to perform preventive health behaviors: An application of the protection motivation theory. 2011
- Conditional survival of patients with esophageal cancer: A SEER database analysis. 2011
- Evaluation of variants of the rs1934951 locus of CYP2C8 and bisphosphonate-related osteonecrosis of the jaw in castrate-resistant prostate cancer (CRPC) patients. 2010
- A polymorphism in a transporter of testosterone as a determinant of androgen independence in prostate cancer 2008
Research
category
- ONCOLOGY Category
Identity
International Standard Serial Number (ISSN)
- 0732-183X
Electronic International Standard Serial Number (EISSN)
- 1527-7755
Other
journal abbreviation
- J CLIN ONCOL